Trial Outcomes & Findings for Clinical Comparison of Two Daily Disposable Toric Soft Contact Lenses (NCT NCT05483127)

NCT ID: NCT05483127

Last Updated: 2023-11-02

Results Overview

Distance visual acuity (VA) was assessed with study lenses in place. VA was collected for each eye separately using logarithmic of the Minimum Angle of Resolution (logMAR) charts. LogMAR typically ranges from -0.3 (20/10 vision on the Snellen chart) to 1 (20/200 vision). A logMAR acuity of 0.0 corresponds to 20/20 Snellen (normal distance visual acuity), with a negative value denoting better than 20/20 visual acuity.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

153 participants

Primary outcome timeframe

Day 8 of each study lens type worn during the corresponding crossover period

Results posted on

2023-11-02

Participant Flow

Participants were recruited from 11 investigative sites located in the United States.

Of the 153 enrolled, 1 participant was exited prior to randomization as a screen failure. This reporting group includes all randomized participants (152).

Participant milestones

Participant milestones
Measure
P1fA, Then MDT
Verofilcon A toric soft contact lenses worn first, followed by stenfilcon A toric soft contact lenses, as randomized. Each study lens type was worn for 8 (-0/+3) days for at least 10 hours per day. Lenses were removed nightly and disposed of after a single use.
MDT, Then P1fA
Stenfilcon A toric soft contact lenses worn first, followed by verofilcon A toric soft contact lenses, as randomized. Each study lens type was worn for 8 (-0/+3) days for at least 10 hours per day. Lenses were removed nightly and disposed of after a single use.
First Wear Period, 8 (-0/+3) Days
STARTED
77
75
First Wear Period, 8 (-0/+3) Days
COMPLETED
77
75
First Wear Period, 8 (-0/+3) Days
NOT COMPLETED
0
0
Second Wear Period, 8 (-0/+3) Days
STARTED
76
75
Second Wear Period, 8 (-0/+3) Days
COMPLETED
76
75
Second Wear Period, 8 (-0/+3) Days
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Clinical Comparison of Two Daily Disposable Toric Soft Contact Lenses

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
P1fA, Then MDT
n=77 Participants
Verofilcon A toric soft contact lenses worn first, followed by stenfilcon A toric soft contact lenses, as randomized. Each study lens type was worn for 8 (-0/+3) days for at least 10 hours per day. Lenses were removed nightly and disposed of after a single use.
MDT, Then P1fA
n=75 Participants
Stenfilcon A toric soft contact lenses worn first, followed by verofilcon A toric soft contact lenses, as randomized. Each study lens type was worn for 8 (-0/+3) days for at least 10 hours per day. Lenses were removed nightly and disposed of after a single use.
Total
n=152 Participants
Total of all reporting groups
Age, Continuous
34.6 years
STANDARD_DEVIATION 9.4 • n=93 Participants
34.3 years
STANDARD_DEVIATION 8.6 • n=4 Participants
34.4 years
STANDARD_DEVIATION 9.0 • n=27 Participants
Sex: Female, Male
Female
48 Participants
n=93 Participants
46 Participants
n=4 Participants
94 Participants
n=27 Participants
Sex: Female, Male
Male
29 Participants
n=93 Participants
29 Participants
n=4 Participants
58 Participants
n=27 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
12 Participants
n=93 Participants
9 Participants
n=4 Participants
21 Participants
n=27 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
65 Participants
n=93 Participants
66 Participants
n=4 Participants
131 Participants
n=27 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Race/Ethnicity, Customized
White
66 Participants
n=93 Participants
66 Participants
n=4 Participants
132 Participants
n=27 Participants
Race/Ethnicity, Customized
Black or African American
5 Participants
n=93 Participants
5 Participants
n=4 Participants
10 Participants
n=27 Participants
Race/Ethnicity, Customized
American Indian or Alaska Native
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Race/Ethnicity, Customized
Asian
4 Participants
n=93 Participants
4 Participants
n=4 Participants
8 Participants
n=27 Participants
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Race/Ethnicity, Customized
Other
1 Participants
n=93 Participants
0 Participants
n=4 Participants
1 Participants
n=27 Participants
Race/Ethnicity, Customized
Multi-Racial
1 Participants
n=93 Participants
0 Participants
n=4 Participants
1 Participants
n=27 Participants
Region of Enrollment
United States
77 participants
n=93 Participants
75 participants
n=4 Participants
152 participants
n=27 Participants

PRIMARY outcome

Timeframe: Day 8 of each study lens type worn during the corresponding crossover period

Population: Full Analysis Set with data at visit.

Distance visual acuity (VA) was assessed with study lenses in place. VA was collected for each eye separately using logarithmic of the Minimum Angle of Resolution (logMAR) charts. LogMAR typically ranges from -0.3 (20/10 vision on the Snellen chart) to 1 (20/200 vision). A logMAR acuity of 0.0 corresponds to 20/20 Snellen (normal distance visual acuity), with a negative value denoting better than 20/20 visual acuity.

Outcome measures

Outcome measures
Measure
PRECISION1 for Astigmatism (P1fA)
n=151 Participants
Verofilcon A toric soft contact lenses worn during Period 1 or Period 2, as randomized. The study lenses were worn for 8 (-0/+3) days for at least 10 hours per day. Lenses were removed nightly and disposed of after a single use.
MyDay Toric (MDT)
n=302 eyes
Stenfilcon A toric soft contact lenses worn during Period 1 or Period 2, as randomized. The study lenses were worn for 8 (-0/+3) days for at least 10 hours per day. Lenses were removed nightly and disposed of after a single use.
Least Squares Means Distance Visual Acuity With Study Lenses at Week 1
-0.11 logMAR
Standard Error 0.005
-0.10 logMAR
Standard Error 0.005

Adverse Events

Pretreatment

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

P1fA Ocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

P1fA Non-Ocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

MDT Ocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

MDT Non-Ocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Associate Director, CRD Vision Care

Alcon Research, LLC

Phone: 1-888-451-3937

Results disclosure agreements

  • Principal investigator is a sponsor employee Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
  • Publication restrictions are in place

Restriction type: OTHER